Sydney-based asset manager Regal Partners Ltd suffered a setback on Friday after shares in one of its portfolio companies, Immutep Ltd, collapsed following the discontinuation of a clinical trial for a lung cancer treatment, according to a report by Bloomberg. 13.03.2026















